Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Donald A Bergstrom

President at Relay Therapeutics, Inc. (RLAY)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.4M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 9SEC RLAYRelay Therapeutics, Inc. Sell Plan 8,530399,130 held (−2%) $18.97 $162K -5.7%
Jul 30SEC RLAYRelay Therapeutics, Inc. Sell 2,237407,660 held (−1%) $18.61 $42K -3.9%
Jul 8SEC RLAYRelay Therapeutics, Inc. Sell Plan 8,660409,897 held (−2%) $18.71 $162K -4.4%
Jun 24SEC RLAYRelay Therapeutics, Inc. Sell Plan 93,456418,557 held (−18%) $16.94 $1.6M +5.5%
Apr 30SEC RLAYRelay Therapeutics, Inc. Sell 1,490418,557 held (−0%) $14.79 $22K +20.9%
Jan 29SEC RLAYRelay Therapeutics, Inc. Sell 18,895422,733 held (−4%) $7.62 $144K +134.6%
Jan 29SEC RLAYRelay Therapeutics, Inc. Sell 2,686420,047 held (−1%) $8.45 $23K +111.6%
Oct 30SEC RLAYRelay Therapeutics, Inc. Sell 30,897521,823 held (−6%) $7.29 $225K +145.3%
  • Sell

    President Donald A Bergstrom sold $162K of RLAY at $18.97 — pre-scheduled 10b5-1 plan sale.

  • Sell

    President Donald A Bergstrom sold $162K of RLAY at $18.71 — pre-scheduled 10b5-1 plan sale.

  • Sell

    President Donald A Bergstrom sold $1.6M of RLAY at $16.94 — pre-scheduled 10b5-1 plan sale.